ACG Expands Barrier Film Capacity

MUMBAI, IndiaACG Worldwide expanded its operations, adding a 200,000-sq.-ft. manufacturing facility, ACG Pharmapack, dedicated to a full range of films from mono PVC and Aclar and other laminates, PVdC suppository films, BAREX, calendarable PETG and more. The new facility triples ACG Pharmapack's films output while maintaining the high quality associated with ACG products. The facility is ISO 9001:2000 and ISO 1400:2004 certified, conforms to cGMP norms and is on par with class 100000 guidelines. In addition, ACG Pharmapak has a DMF registration with the US FDA, meets EC norms, has an EMS certification and is registered with SFDA-China and the Canadian Health Department.

We are using the latest technology in this plant, keeping in mind the requirements of our domestic and overseas customers," said Michael Franklin, CEO of ACG Pharmapack. We are planning 300 percent expansion in the next three years. Currently the production capacity of this plant is more than 18,000 tonsor 40 million poundsper year."